• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

经皮主动脉瓣狭窄和二尖瓣反流同期治疗：首例人体病例描述。

Percutaneous treatment of aortic stenosis and mitral regurgitation in the same patient: first human cases description.

机构信息

Division of Cardiology, Ferrarotto Hospital, University of Catania, Italy.

出版信息

Catheter Cardiovasc Interv. 2011 Oct 1;78(4):650-5. doi: 10.1002/ccd.23015. Epub 2011 Jul 25.

DOI:10.1002/ccd.23015
PMID:21793170
Abstract

Transcatheter valve therapy is becoming an established treatment for aortic stenosis (AS) and it is very promising for mitral regurgitation (MR). There are no formal reports of percutaneous treatment of both AS and MR in the same patient. Here, we report on the first human cases of successful totally percutaneous management of combined severe AS and MR as a planned staged approach and using MitraClip(®) implantation as a procedure necessitated by an unpredictable complication of self-expanding CoreValve device, respectively.

摘要

经导管瓣膜治疗技术已成为主动脉瓣狭窄（AS）的一种成熟治疗方法，对于二尖瓣反流（MR）也极具应用前景。目前尚无在同一患者中同时行经皮治疗 AS 和 MR 的正式报告。在此，我们报告首例成功的人类联合重度 AS 和 MR 的完全经皮治疗病例，分别采用计划分期方法和经皮植入 MitraClip（®）作为自膨式 CoreValve 装置出现不可预测并发症的必要治疗程序。

相似文献

1
Percutaneous treatment of aortic stenosis and mitral regurgitation in the same patient: first human cases description.经皮主动脉瓣狭窄和二尖瓣反流同期治疗：首例人体病例描述。
Catheter Cardiovasc Interv. 2011 Oct 1;78(4):650-5. doi: 10.1002/ccd.23015. Epub 2011 Jul 25.
2
Echocardiography in transcatheter aortic valve implantation and mitral valve clip.经导管主动脉瓣植入术和二尖瓣夹合术中的心超检查。
Korean J Intern Med. 2012 Sep;27(3):245-61. doi: 10.3904/kjim.2012.27.3.245. Epub 2012 Sep 1.
3
Acute mitral regurgitation complicating transcatheter aortic valve implantation.经导管主动脉瓣植入术并发急性二尖瓣反流
J Heart Valve Dis. 2011 May;20(3):361-3.
4
Abnormal distortion of aortic corevalve bioprosthesis with suicide left ventricle, aortic insufficiency, and severe mitral regurgitation during transcatheter aortic valve replacement.经导管主动脉瓣置换术中主动脉生物瓣膜异常变形伴左心室自杀、主动脉瓣关闭不全和严重二尖瓣反流。
Catheter Cardiovasc Interv. 2016 Dec;88(7):1181-1187. doi: 10.1002/ccd.26463. Epub 2016 Mar 4.
5
Influence of CoreValve ReValving System implantation on mitral valve function: an echocardiographic study in selected patients.经心尖 CoreValve ReValving 系统植入术对二尖瓣功能的影响：一项针对特定患者的超声心动图研究。
Catheter Cardiovasc Interv. 2011 Oct 1;78(4):638-44. doi: 10.1002/ccd.23045. Epub 2011 Jul 29.
6
Transcatheter aortic valve implantation in a patient with mechanical mitral prosthesis: a lesson learned from an intraventricular clash.经导管主动脉瓣植入术治疗机械二尖瓣假体患者：来自心室内碰撞的教训。
Catheter Cardiovasc Interv. 2013 Oct 1;82(4):E621-5. doi: 10.1002/ccd.24948. Epub 2013 May 28.
7
Transcatheter Mitral Valve Implantation in a Patient With an Aortic Mechanical Valve.主动脉机械瓣置换术后患者的经导管二尖瓣植入术
JACC Cardiovasc Interv. 2016 Feb 22;9(4):e31-e33. doi: 10.1016/j.jcin.2015.10.048.
8
Transseptal approach for the management of paravalvular regurgitation after transcatheter aortic valve replacement.经导管主动脉瓣置换术后瓣周漏的经房间隔入路处理。
Catheter Cardiovasc Interv. 2013 Oct 1;82(4):E587-91. doi: 10.1002/ccd.24678. Epub 2013 Mar 25.
9
Reoperative "valve-in-valve" transapical transcatheter mitral valve replacement in a high-risk patient with a recent transapical transcatheter aortic valve replacement and a degenerated bioprosthetic mitral valve.在一位近期接受经心尖经导管主动脉瓣置换术且生物瓣二尖瓣退变的高危患者中进行再次手术“瓣中瓣”经心尖经导管二尖瓣置换术
J Thorac Cardiovasc Surg. 2014 Nov;148(5):e209-10. doi: 10.1016/j.jtcvs.2014.07.011. Epub 2014 Jul 30.
10
Staged total percutaneous treatment of aortic valve pathology and mitral regurgitation: institutional experience.分期全经皮主动脉瓣病变和二尖瓣反流治疗：机构经验。
Catheter Cardiovasc Interv. 2013 Oct 1;82(4):E552-63. doi: 10.1002/ccd.24809. Epub 2013 May 25.

引用本文的文献

1
Mixed-Valve Disease: Management of Patients with Aortic Stenosis and Mitral Regurgitation: Thresholds for Surgery Versus Percutaneous Therapies.混合瓣膜病：主动脉瓣狭窄合并二尖瓣反流患者的管理：手术与经皮治疗的阈值
US Cardiol. 2021 Nov 29;15:e26. doi: 10.15420/usc.2021.17. eCollection 2021.
2
Sequential Percutaneous Approach for Severe Mitral and Aortic Regurgitation.用于重度二尖瓣和主动脉瓣反流的序贯经皮入路
Cureus. 2020 Jan 10;12(1):e6619. doi: 10.7759/cureus.6619.
3
A Glimpse into the Future: In 2020, Which Patients will Undergo TAVI or SAVR?
展望未来：2020年，哪些患者将接受经导管主动脉瓣置入术（TAVI）或外科主动脉瓣置换术（SAVR）？
Interv Cardiol. 2017 May;12(1):44-50. doi: 10.15420/icr.2016:24:2.
4
Impact of Mitral Regurgitation on Clinical Outcomes After Transcatheter Aortic Valve Implantation.二尖瓣反流对经导管主动脉瓣植入术后临床结局的影响。
Interv Cardiol. 2016 May;11(1):54-58. doi: 10.15420/icr.2016:11:1.